Sarah Goral, PA
Physician Assistant · Mitchell, SDNPI 1689986788
Payments from drug & device makers
Across 478 payments — averaging $12.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Amgen$856
- Pfizer$655
- Boehringer Ingelheim$573
- Johnson & Johnson$397
- AstraZeneca$385
- plus $2K from 32 others
What the payments were for
- Food & beverage$5,957100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 79 | $1,084 |
| Amgen | 77 | $856 |
| Pfizer | 63 | $655 |
| Boehringer Ingelheim | 46 | $573 |
| Johnson & Johnson | 66 | $397 |
| AstraZeneca | 14 | $385 |
| Novo Nordisk | 16 | $231 |
| AbbVie | 12 | $185 |
| Abbott | 10 | $171 |
| Astellas Pharma US Inc | 10 | $166 |
| Merck | 12 | $164 |
| Novartis | 7 | $122 |
| E.r. Squibb & Sons, L.L.C. | 8 | $116 |
| Grifols USA, LLC | 5 | $108 |
| Amarin Pharma, Inc. | 7 | $92 |
| GSK | 5 | $66 |
| Daiichi Sankyo Inc. | 4 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Mylan Specialty L.p. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Medtronic | 2 | $30 |
| Lundbeck LLC | 2 | $28 |
| Exact Sciences | 2 | $28 |
| Sanofi-aventis U.S. LLC | 2 | $24 |
| Biogen | 2 | $23 |
| Conetic Solutions, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Mimedx Group, Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Genentech USA, Inc. | 3 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,957 in reported general payments places this provider in the 95th percentile of 548 physician assistant providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 32 | $31,288 |
| OzempicSemaglutide | 13 | $12,386 |
| EliquisApixaban | 13 | $6,613 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,996 |
| Carvedilol ErCarvedilol Phosphate | 11 | $1,980 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 22 | $1,285 |
| Atorvastatin Calcium | 123 | $1,277 |
| Levothyroxine Sodium | 143 | $914 |
| Rosuvastatin Calcium | 46 | $909 |
| CefuroximeCefuroxime Axetil | 58 | $895 |
| Potassium Chloride | 73 | $873 |
| Ezetimibe | 11 | $841 |
| Omeprazole | 105 | $760 |
| Olmesartan Medoxomil | 13 | $643 |
| Metoprolol Succinate | 50 | $616 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $397 | $31,28832 claims |
| Novo NordiskOzempic | $231 | $12,38613 claims |
| PfizerEliquis | $655 | $6,61313 claims |
| GSKBreo Ellipta | $66 | $4,99613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 548 physician assistant providers in South Dakota.
Other physician assistant in Mitchell
- Kimberly NelsonSioux Falls$11K
- Jordan HeinsRapid City$10K
- Ryanne WaageAberdeen$9K
- Christina PekoskeSioux Falls$9K
- Rachel HotvetSioux Falls$8K
- Jarrett FowlerRapid City$7K
- Jerome WenningerRapid City$7K
- Alyssa MrsnyDakota Dunes$7K
- Gabriel PenaredondoSioux Falls$7K
- David KingNorth Sioux City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.